Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

PR Newswire
July 20, 2020 — 08:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Beijing China Dollar Employee Export Exports Fidelity finance guangdong healthcare Hillhouse Capital Group Hong Kong internet investment JD finance manufacturing medicine Meituan Dianping Pacific pharmaceutical Private Equity Qiming Venture Partners real estate Renminbi retail Seattle Shanghai shenzhen singapore software stock exchange stock market Suzhou technology Ubtech venture capital Xiaomi Zoom

Related News:

Terra Drone, Unifly, and Aloft Technologies Launch UTM Development for AAM Targeting Global Markets

April 25, 2024 — 07:00

Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever

April 24, 2024 — 13:00

Zepp Health Corporation Files 2023 Annual Report on Form 20-F

April 23, 2024 — 20:20

TTC Announces Strategic Expansion into Western Australia with New Perth Office

April 23, 2024 — 04:00

Tantech Holdings Ltd Announces $2.1 Million Private Placement

April 23, 2024 — 03:58

Latham Adds Experienced M&A Partner in Tokyo

April 23, 2024 — 03:15

DFI and Outdoor LCD Manufacturer ODHitec Introduce Charging Station Solutions at EVS37

April 22, 2024 — 10:00

GT20029 China Phase II Trial For AGA Reached Primary Endpoint

April 22, 2024 — 09:53

Mayur achieves major milestone with US$155 million for Central Lime Project in Papua New Guinea

April 22, 2024 — 09:38